CCDC192: A Potential Drug Target and Biomarker (G728586)

Target Name: CCDC192

NCBI ID: G728586

CCDC192

Other Name(s): coiled-coil domain containing 192 | LINC01183 | LINC01183 variant X2 | long intergenic non-protein coding RNA 1183 | Long intergenic non-protein coding RNA 1183, transcript variant X2

CCDC192: A Potential Drug Target and Biomarker

CDC192, also known as coiled-coil domain containing 192, is a protein that plays a crucial role in cellular signaling. It is a 192-kDa protein that is expressed in various tissues and cells, including brain, heart, and muscle. CDC192 is known for its unique structure, which consists of a long coiled-coil domain that is responsible for its unique physical and functional properties.

CDC192 functions as a negative regulator of the Wnt signaling pathway, which is a well-established pathway that plays a crucial role in the development, maintenance, and repair of tissues. The Wnt signaling pathway is a highly conserved signaling pathway that is involved in numerous cellular processes, including cell growth, differentiation, and survival.

CDC192's unique structure and function make it an attractive drug target and biomarker. Its structure allows it to interact with small molecules, making it a potential target for drugs that can modulate its activity. Additionally, its functions in the Wnt signaling pathway make it a potential biomarker for diseases associated with Wnt signaling pathway dysfunction.

CDC192's Structure and Functions

CDC192 is a protein that consists of a pre-protein molecule and a single 192-kDa protein. The pre-protein molecule consists of a transmembrane domain, a cytoplasmic domain, and a soluble domain. The transmembrane domain is responsible for protein-protein interactions and the cytoplasmic domain is responsible for the protein's localization to the cytoplasm. The soluble domain is responsible for the protein's stability and functions as a negative regulator of the Wnt signaling pathway.

CDC192's unique structure is its most noteworthy feature. It consists of a long coiled-coil domain that is responsible for the protein's unique physical and functional properties. The coiled-coil domain is responsible for the protein's ability to interact with small molecules, which makes it a potential target for drugs that can modulate its activity.

In addition to its unique structure, CDC192 plays a crucial role in the regulation of the Wnt signaling pathway. It is a negative regulator of the pathway, which means that it works to reduce the activity of Wnt proteins. The Wnt proteins are involved in the development, maintenance, and repair of tissues, and are known for their role in the development of cancer. By regulating the activity of Wnt proteins, CDC192 plays a crucial role in the regulation of tissue growth and development.

CDC192's functions in the Wnt signaling pathway are also of interest as a potential drug target or biomarker. The pathway is involved in the development and maintenance of tissues, including the nervous system, and is known for its role in the development of cancer. By targeting CDC192, drugs can modulate the activity of Wnt proteins and potentially lead to the inhibition of cancer growth.

CDC192 as a Potential Drug Target

CDC192's unique structure and functions make it an attractive target for drugs that can modulate its activity. Its long coiled-coil domain, which is responsible for its unique physical and functional properties, makes it a potential target for small molecules that can interact with it. Additionally, its role as a negative regulator of the Wnt signaling pathway makes it a potential target for drugs that can modulate the activity of Wnt proteins.

CDC192's functions in the Wnt signaling pathway make it an attractive target for drugs that can inhibit its activity. The pathway is involved in the development and maintenance of tissues, including the nervous system, and is known for its role in the development of cancer. By targeting CDC192, drugs can potentially inhibit the activity of Wnt proteins and lead to the inhibition of cancer growth.

CDC192 as a Potential Biomarker

CDC192's unique structure and functions also make it an attractive biomarker for diseases associated with the Wnt signaling pathway. The pathway is involved in the development and maintenance of tissues, including the nervous system, and is known for its role in the development of cancer. By targeting CDC192, drugs can potentially modulate its activity and identify diseases associated with the Wnt signaling pathway dysfunction.

In addition to its potential as a drug target, CDC192 is also a potential biomarker for diseases associated with the Wnt signaling pathway dysfunction. The pathway is involved in the development and maintenance of tissues, including the nervous system, and is known for its role in the development of cancer. By targeting CDC192, drugs can potentially modulate its activity and identify diseases associated with the Wnt signaling pathway dysfunction.

Conclusion

CDC192 is a protein that plays a crucial role in cellular signaling, particularly in the regulation of the Wnt signaling pathway. Its unique structure and functions make it an attractive drug target and biomarker. Its long coiled-coil domain, which is responsible for its unique physical and functional properties, makes it a potential target for small molecules that can interact with it. Additionally, its role as a negative regulator of the Wnt signaling pathway makes it a potential target for drugs that can modulate its activity.

CDC192's functions in the Wnt signaling pathway also make it an attractive target for drugs that can inhibit its activity. The pathway is involved in the development and maintenance of tissues, including the nervous system, and is known for its role in the development of cancer. By targeting CDC192, drugs can potentially inhibit the activity of Wnt proteins and lead to the inhibition of cancer growth.

Moreover, CDC192's unique structure and functions also make it an attractive biomarker for diseases associated with the Wnt signaling pathway dysfunction. The pathway is involved in the development and maintenance of tissues, including the nervous system, and is known for its role in the development of cancer. By targeting CDC192, drugs can potentially modulate its activity and identify diseases associated with the Wnt signaling pathway dysfunction.

Overall, CDC192 is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Its unique structure and functions make it an attractive target for small molecules that can interact with it, and its role as a negative regulator of the Wnt signaling pathway makes it a potential target for drugs that can modulate its activity. Additionally, its functions in the pathway make it a potential biomarker for diseases associated with the pathway dysfunction.

Protein Name: Coiled-coil Domain Containing 192

The "CCDC192 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC192 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets